The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.  
View all videos

EHA 2022

EHA 2022
09–12 June 2022 | Vienna Austria / Online

Tracy George (@UUtah) discusses responses to avapritinib in patients with advanced systemic mastocytosis at #EHA2022:

👉http://ow.ly/e4wc50JKBmJ👈

@EHA_Hematology #HemOnc #RareDiseases #MPNsm #Mastocytosis

I strongly recommend this beautiful review on mantle cell lymphoma published in the ⁦@NEJM⁩
Amazing advances in this disease over the last 10 years.
⁩ ⁦@TheIACH⁩

Register for the IACH webinar on Managing toxicities in relapsed/refractory multiple myeloma: expert-led case discussions
Thursday July 7, 2022
6:00pm (Paris), 5:00pm (London), 12:00pm (New York), 9:00am (Los Angeles)
FREE Registration: https://us06web.zoom.us/webinar/register/WN_E7T9zIOpTRCqfcihDDCvmg
@Mohty_EBMT

#iwCART22 | Leading experts John Gribben, Mazyar Shadman, and Saar Gill discuss some of the barriers to CAR-T therapy in CLL & debate the optimal use of CAR-T in CLL:

🎥: http://ow.ly/Mp1V50JA5ko

#CLLsm #LeuSM #ImmunoOnc #HemOnc #CARTcell #tcellrx

Load More...

EHA 2022

EHA 2022
09–12 June 2022 | Vienna Austria / Online
The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.  
View all videos

Tracy George (@UUtah) discusses responses to avapritinib in patients with advanced systemic mastocytosis at #EHA2022:

👉http://ow.ly/e4wc50JKBmJ👈

@EHA_Hematology #HemOnc #RareDiseases #MPNsm #Mastocytosis

I strongly recommend this beautiful review on mantle cell lymphoma published in the ⁦@NEJM⁩
Amazing advances in this disease over the last 10 years.
⁩ ⁦@TheIACH⁩

Register for the IACH webinar on Managing toxicities in relapsed/refractory multiple myeloma: expert-led case discussions
Thursday July 7, 2022
6:00pm (Paris), 5:00pm (London), 12:00pm (New York), 9:00am (Los Angeles)
FREE Registration: https://us06web.zoom.us/webinar/register/WN_E7T9zIOpTRCqfcihDDCvmg
@Mohty_EBMT

#iwCART22 | Leading experts John Gribben, Mazyar Shadman, and Saar Gill discuss some of the barriers to CAR-T therapy in CLL & debate the optimal use of CAR-T in CLL:

🎥: http://ow.ly/Mp1V50JA5ko

#CLLsm #LeuSM #ImmunoOnc #HemOnc #CARTcell #tcellrx

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter